EP3013318
Stöðug vökvaformúla AMG 416 (velkalsetíð)
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
27.6.2014EP published:
19.4.2017EP application number:
14742093.9
EP translation filed:
11.7.2017Grant published:
15.8.2017EPO information:
European Patent Register
Max expiry date:
26.6.2034Expiry date:
26.6.2026Next due date:
30.6.2026
Title:
STABLE LIQUID FORMULATION OF AMG 416 (VELCALCETIDE)
Timeline
Today
27.6.2014EP application
19.4.2017EP Publication
11.7.2017Translation submitted
15.8.2017Registration published
26.6.2026Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, 91320, Thousand Oaks, CA, US
Inventor
Name:
MACLEAN, DerekAddress:
Los Altos, California, US
Name:
YIN, QunAddress:
Palo Alto, California, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361840618 PDate:
28.6.2013Country:
US
Classification
Categories:
A61K 9/08, A61K 38/08, A61P 5/00, A61P 3/14
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 26.6.2017
Expires: 26.6.2018
Payer: Árnason Faktor
Number: 5
Paid: 14.5.2018
Expires: 26.6.2019
Payer: Árnason Faktor
Number: 6
Paid: 8.5.2019
Expires: 26.6.2020
Payer: Árnason Faktor
Number: 7
Paid: 5.5.2020
Expires: 26.6.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 11.5.2021
Expires: 26.6.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 18.5.2022
Expires: 26.6.2023
Payer: Patice ehf.
Number: 10
Paid: 24.5.2023
Expires: 26.6.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 23.5.2024
Expires: 26.6.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 16.6.2025
Expires: 26.6.2026
Payer: Árnason Faktor ehf.